In conclusion, these findings emphasize the critical role of NDRG1 in shaping the tumor microenvironment through lactate‐mediated mechanisms, and targeting NDRG1 in combination with strategies to modulate lactate metabolism may significantly improve the effectiveness of immunotherapy in treating lung adenocarcinoma. This evidence concerns the gene NDRG1 and lung adenocarcinoma.